Hsp70
Hsp70 protein | |||||||||
---|---|---|---|---|---|---|---|---|---|
|
The 70 kilodalton heat shock proteins (Hsp70s or DnaK) are a
Discovery
Members of the Hsp70 family are very strongly upregulated by heat stress and
Structure
The Hsp70 proteins have three major functional domains:
- N-terminal ATPase domain – binds ATP (Adenosine triphosphate) and hydrolyzes it to ADP (Adenosine diphosphate). The NBD (nucleotide binding domain) consists of two lobes with a deep cleft between them, at the bottom of which nucleotide (ATP and ADP) binds. The exchange of ATP and ADP leads to conformational changes in the other two domains.
- Substrate binding domain – is composed of a 15 β barrel, which enclose the peptide backbone of the substrate. SBD contains a groove with an affinity for neutral, hydrophobic amino acidresidues. The groove is long enough to interact with peptides up to seven residues in length.
- C-terminal domain – rich in alpha helical structure acts as a 'lid' for the substrate binding domain. The helical subdomain consists of five helices, with two helices packed against two sides of the β sheet subdomain, stabilizing the inner structure. In addition, one of the helix forms a salt bridge and several hydrogen bonds to the outer Loops, thereby closing the substrate-binding pocket like a lid. Three helices in this domain form another hydrophobic core which may be stabilization of the "lid". When an Hsp70 protein is ATP bound, the lid is open and peptides bind and release relatively rapidly. When Hsp70 proteins are ADP bound, the lid is closed, and peptides are tightly bound to the substrate binding domain.[9]
Protein phosphorylation, a post-translational modification, helps to regulate protein function and involves the phosphorylation of amino acids with hydroxyl groups in their side chains (among eukaryotes). Serine, threonine, and tyrosine amino acids are common targets of phosphorylation. Phosphorylation of Hsp70 has become a point of greater exploration in scientific literature relatively recently. A 2020 publication suggests that phosphorylation of a serine residue between the NBD and substrate binding domain in yeast Hsp70s leads to a dramatic reduction of the normal Hsp70 heat shock response.[10] This deactivation via phosphorylation of a protein is a common motif in protein regulation, and demonstrates how relatively small changes to protein structure can have biologically significant effects on protein function.
Function
The Hsp70 system interacts with extended peptide segments of proteins as well as partially folded proteins to cause aggregation of proteins in key pathways to downregulate activity.
By binding tightly to partially synthesized peptide sequences (incomplete proteins), Hsp70 prevents them from aggregating and being rendered nonfunctional. Once the entire protein is synthesized, a nucleotide exchange factor (prokaryotic GrpE, eukaryotic BAG1 and HspBP1 are among those which have been identified) stimulates the release of ADP and binding of fresh ATP, opening the binding pocket. The protein is then free to fold on its own, or to be transferred to other chaperones for further processing.[12] HOP (the Hsp70/Hsp90 Organizing Protein) can bind to both Hsp70 and Hsp90 at the same time, and mediates the transfer of peptides from Hsp70 to Hsp90.[13]
Hsp70 also aids in transmembrane transport of proteins, by stabilizing them in a partially folded state. It is also known to be phosphorylated[14] which regulates several of its functions.[15][16][17]
Hsp70 proteins can act to protect cells from thermal or oxidative stress. These stresses normally act to damage proteins, causing partial unfolding and possible aggregation. By temporarily binding to hydrophobic residues exposed by stress, Hsp70 prevents these partially denatured proteins from aggregating, and inhibits them from refolding. Low ATP is characteristic of heat shock and sustained binding is seen as aggregation suppression, while recovery from heat shock involves substrate binding and nucleotide cycling. In a thermophile anaerobe (Thermotoga maritima) the Hsp70 demonstrates redox sensitive binding to model peptides, suggesting a second mode of binding regulation based on oxidative stress.
Hsp70 seems to be able to participate in disposal of damaged or defective proteins. Interaction with CHIP (Carboxyl-terminus of Hsp70 Interacting Protein)–an E3 ubiquitin ligase–allows Hsp70 to pass proteins to the cell's ubiquitination and proteolysis pathways.[18]
Finally, in addition to improving overall protein integrity, Hsp70 directly inhibits apoptosis.[19] One hallmark of apoptosis is the release of cytochrome c, which then recruits Apaf-1 and dATP/ATP into an apoptosome complex. This complex then cleaves procaspase-9, activating caspase-9 and eventually inducing apoptosis via caspase 3 activation. Hsp70 inhibits this process by blocking the recruitment of procaspase-9 to the Apaf-1/dATP/cytochrome c apoptosome complex. It does not bind directly to the procaspase-9 binding site, but likely induces a conformational change that renders procaspase-9 binding less favorable. Hsp70 is shown to interact with Endoplasmic reticulum stress sensor protein IRE1alpha thereby protecting the cells from ER stress - induced apoptosis. This interaction prolonged the splicing of XBP-1 mRNA thereby inducing transcriptional upregulation of targets of spliced XBP-1 like EDEM1, ERdj4 and P58IPK rescuing the cells from apoptosis.[20] Other studies suggest that Hsp70 may play an anti-apoptotic role at other steps, but is not involved in Fas-ligand-mediated apoptosis (although Hsp 27 is). Therefore, Hsp70 not only saves important components of the cell (the proteins) but also directly saves the cell as a whole. Considering that stress-response proteins (like Hsp70) evolved before apoptotic machinery, Hsp70's direct role in inhibiting apoptosis provides an interesting evolutionary picture of how more recent (apoptotic) machinery accommodated previous machinery (Hsps), thus aligning the improved integrity of a cell's proteins with the improved chances of that particular cell's survival.
In mice, exogenous recombinant human Hsp70 (eHsp70), delivered intranasally, increases lifespan. Although the maximum lifespan increased only moderately, the overall mortality rate in treated animals was much lower compared with the control group. Also this eHsp70-treatment improves learning and memory of mice in old age, increases their curiosity.[21]
Cancer
Hsp70 is overexpressed in
InGiven the role of heat shock proteins as an ancient defense system for stabilizing cells and eliminating old and damaged cells, this system has been co-opted by cancer cells to promote their growth.[26] Increased Hsp70 in particular has been shown to inhibit apoptosis of cancer cells,[27] and increased Hsp70 has been shown to be associated with or directly induce endometrial,[28] lung,[29] colon,[30] prostate,[31] and breast[32] cancer, as well as leukemia.[33] Hsp70 in cancer cells may be responsible for tumorigenesis and tumor progression by providing resistance to chemotherapy. Inhibition of Hsp70 has been shown to reduce the size of tumors and can cause their complete regression.[34] Hsp70/Hsp90 is a particularly attractive target for therapeutics, because it is regulated by the inhibition of its ATPase activity, while other HSPs are regulated by nucleotides.[35] Several inhibitors have been designed for Hsp70 that are currently in clinical trials,[36] though as of now HSP90 inhibitors have been more successful.[37] In addition, Hsp70 has been shown to be a regulator of the immune system, activating the immune system as an antigen.[38] Thus, tumor-derived Hsp70 has been suggested as a potential vaccine [39] or avenue to target for immunotherapy.[40] Given the increased expression of Hsp70 in cancer, it has been suggested as a biomarker for cancer prognostics, with high levels portending poor prognosis.[41] An oncogenic mechanism illustrates how extracellular vesicles expressing HSP70 are produced by proliferative Acute Lymphoblastic Leukemia cells and can target and compromise a healthy hematopoiesis system during leukemia development.[42]
Expression in skin tissue
Both Hsp70 and
Neurodegeneration
Inhibition of Hsp90 leads to Hsp70 and Hsp40 upregulation, which can channel misfolded protein for proteasome degradation, which can potentially inhibit the progression of neurodegenerative diseases.[45] For example, Hsp70 overexpression in human neuroglioma cells transfected with mutant alpha-synuclein led to 50% less oligomeric alpha-synuclein species,[46] pointing towards the possibility that increasing its expression could diminish the spread of Parkinson's disease. Similarly, Hsp70 overexpression suppressed poly-Q dependent aggregation and neurodegeneration in cell cultures, yeast,[47] fly,[48] and mouse [49] models, and deletion of hsp70 increased the size of polyQ inclusion bodies,[50] suggesting that increasing its expression could help to prevent Huntington's disease. Similarly, reductions in Hsp70 have been shown in transgenic mouse models of ALS and patients with sporadic ALS.[51] Lastly, increased expression or activity of Hsp70 has been proposed as a method to prevent the progression of Alzheimer's disease, because knock down of Hsp70 promoted A-beta toxicity,[52] and Hsp70 was shown to promote tau stability, while Hsp70 levels are decreased in tauopathies like Alzheimer's disease.[53] Given the complex interplay between the different chaperone proteins, therapeutic development in this field is aimed at investigating how the chaperone network as a whole can be manipulated and the effect of this manipulation on the progression of neurodegenerative disease, but the balance of Hsp70 and Hsp90 levels appears to be central in this pathophysiology.
In diabetes
The fluctuations in the levels of chaperone HSP70 affect the homeostasis. Diabetes leads to several microvasculature and microvasculature diseases like retinopathy, Toll like receptors are integral part of innate immune system and eHSP70 binds to toll like receptors and activates the MyD88 pathway, further stimulating NF-kB, cytokines like TNFα and IL1 β, increased production of reactive oxygen species contributing to insulin resistance and diabetes. Whereas there is decrease in the levels of iHSP70.[54]
In cardiovascular diseases
HSP70 is a chaperone with ubiquitous presence.[55] It is crucial in the cardiovascular system. HSP70 normally aids in protein folding and aggregation; when present in the cell, functioning as an anti-inflammatory molecule; however, under stress conditions, it is localized to the extracellular milieu, where it is involved in inducing inflammatory pathways and contributes to disease pathogenesis.[56] It is well established that intracellular HSP70 (iHSP70) levels play a protective role, whereas extracellular HSP70 (eHSP70) levels in circulating blood are linked to pathophysiology in micro and microvasculature, which results in a variety of cardiovascular illnesses. HSP70 homologues identified in human cytosol includes HSPA1A, HSPA1B, HSPA1L, HSPA12B, HSPA13, HSPA14 whereas HSPA9 in mitochondria. The HSP70 acts as DAMP and activates innate immune response which as involved in cardiovascular disease progression.[57]
The chaperone protein acts as auto antigen in atherosclerosis. Increased oxidative stress causes the formation of high-density oxidized LDL, the first event in the formation of plaque. This activates HSP70 and its promoter in the endothelial and smooth muscle cells, which contributes to atherosclerosis by inducing JAK/STAT pathway expression.[58][59]
HSP70 is also linked to high blood pressure, a worldwide concern and risk factor for a variety of cardiovascular diseases. Hypertension causes endothelial dysfunction and vascular wall damage, both of which contribute to arterial stiffness and atherosclerosis.[60] HSPA1A, HSPA1B, and HSPA1L are three genes in humans that encode HSP70, and their polymorphism is linked to the onset of high blood pressure and cardiovascular disease.[61] Angiotensin II, endothelin-1, or phenylepinephrine cause HSP70 overexpression, which activates several molecular pathways, resulting in increased production of ROS, CRP, IL-10, TNF-alpha, and IL-6 [62][61] These inflammatory signals interfere with the antioxidant machinery and results in rapid disease progression.
HSP70 expression increases after the coronary bypass surgery. Exercise has a positive and protective impact on cardiovascular disorders and stimulates the increased production of chaperone protein together known to be cardioprotective.
Family members
Prokaryotes express three Hsp70 proteins: DnaK, HscA (Hsc66), and HscC (Hsc62).[63]
Eukaryotic organisms express several slightly different Hsp70 proteins. All share the common domain structure, but each has a unique pattern of expression or subcellular localization. These are, among others:
- Hsc70 (Hsp73/HSPA8) is a constitutively expressed chaperone protein. It typically makes up one to three percent of total cellular protein.
- Hsp70 (encoded by three very closely related paralogs: HSPA1A, HSPA1B, and HSPA1L) is a stress-induced protein. High levels can be produced by cells in response to hyperthermia, oxidative stress, and changes in pH.
- Binding immunoglobulin protein (BiP or Grp78) is a protein localized to the endoplasmic reticulum. It is involved in protein folding there, and can be upregulated in response to stress or starvation.
- mtHsp70 or Grp75 is the mitochondrial Hsp70.
The following is a list of human Hsp70 genes and their corresponding proteins:[2]
gene | protein | synonyms | subcellular location |
---|---|---|---|
HSPA1A | Hsp70 | HSP70-1, Hsp72 | Cyto
|
HSPA1B | Hsp70 | HSP70-2 | Nuc/Cyto |
HSPA1L | Hsp70 | ? | |
HSPA2 | Hsp70-2 | ? | |
HSPA5 | Hsp70-5 | BiP/Grp78 | ER |
HSPA6 | Hsp70-6 | ? | |
HSPA7 | Hsp70-7 | ? | |
HSPA8 | Hsp70-8 | Hsc70 | Nuc/Cyto |
HSPA9 | Hsp70-9 | Grp75/mtHsp70 | Mito |
HSPA12A | Hsp70-12a | ? | |
HSPA14 | Hsp70-14 | ? |
HSP70s are found in many plants including Arabidopsis, soybean (Glycine max), barley (Hordeum vulgare) and wheat (Triticum aestivum).[64]
Hsps 90 and 110
Hsp90s are essential for protein remodeling, similar to Hsp70 proteins, and play an especially vital role in eukaryotes, where it has been suggested that Hsp90 interacts with the DnaK system (composed of DnaK, GrpE, and either DnaJ or CbpA) to facilitate the process of protein remodeling.[65] In E. coli, Hsp90s works collaboratively with Hsp70s to facilitate protein remodeling and activation. Hsp90Ec and DnaK are chaperones of Hsp90 and Hsp70, respectively. DnaK initially binds and stabilizes the misfolded protein before working collaboratively with Hsp90Ec to refold this substrate and cause its activation. Given conditions of excess DnaK, this chaperone has been found to inhibit remodeling of proteins. However, the presence of Hsp90Ec can mitigate this effect and enable protein remodeling despite conditions of excess DnaK.[66]
The Hsp70 superfamily also includes a family of Hsp110/Grp170 (Sse) proteins, which are larger proteins related to Hsp70.[67] The Hsp110 family of proteins have divergent functions: yeast Sse1p has little ATPase activity but is a chaperone on its own as well as a nucleotide exchange factor for Hsp70, while the closely related Sse2p has little unfoldase activity.[12]
The following is a list of currently named human HSP110 genes. HSPH2-4 are proposed names and the current name is linked:[67]
gene | synonyms | subcellular location |
---|---|---|
HSPH1 | HSP105 | Cyto |
HSPH2 | HSPA4; APG-2; HSP110 | Cyto |
HSPH3 | HSPA4L; APG-1 | Nuc |
HSPH4 | HYOU1/Grp170; ORP150; HSP12A | ER |
See also
References
- S2CID 4338916.
- ^ PMID 9222585.
- S2CID 20917046.
- PMID 28543919.
- PMID 24694368.
- S2CID 32525462.
- PMID 9222594.)
{{cite journal}}
: CS1 maint: DOI inactive as of April 2024 (link - ^ S2CID 226295557.
- PMID 20705236.
- PMID 32205407.
- S2CID 4401991.
- ^ PMID 25487014.
- )
- S2CID 9113738.
- PMID 12080070.
- PMID 23217712.
- S2CID 12604151.
- PMID 10671488.
- S2CID 1507966.
- PMID 20625543.
- PMID 26668376.
- PMID 11237497.
- PMID 17616937.
- S2CID 39372827.
- PMID 27483141.
- PMID 31023024.
- S2CID 201619393.
- PMID 19399947.
- PMID 26579130.
- PMID 27356538.
- PMID 29764864.
- PMID 11795468.
- S2CID 202582093.
- PMID 26898980.
- S2CID 37329279.
- PMID 32121660.
- S2CID 4505299.
- S2CID 24747281.
- PMID 27294301.
- PMID 18089828.
- PMID 32595915.
- S2CID 248127986.
- PMID 23587755.
- PMID 23096703.
- PMID 28559789.
- PMID 18382657.
- PMID 10920207.
- S2CID 24632055.
- S2CID 43035.
- PMID 19605647.
- PMID 26936937.
- PMID 25437566.
- PMID 12522269.
- PMID 32161482.
- PMID 34360841.
- PMID 34572948.
- PMID 20542874.
- S2CID 104325416.
- PMID 23334859.
- PMID 35127755.
- ^ PMID 36416343.
- PMID 26989902.
- PMID 12054669.
- (SEB).
- PMID 21525416.
- PMID 30401745.
- ^ PMID 18663603.
External links
- HSP70+Heat-Shock+Proteins at the U.S. National Library of Medicine Medical Subject Headings (MeSH)